Skip to content
Skillpad_Logo

Founded in 1998 in Dublin, Ireland, Skillpad's team of industry-experienced Subject Matter Experts and Consultants believes Pharma, Biopharma, and Life Science Industry manufacturing companies can achieve production excellence with improved performance, productivity & compliance, as well as reduced losses & down-time, if they have KNOWLEDGE CONSISTENCY in all critical areas of manufacturing operations.

With 25 years in business, and offices in Europe, the USA and Canada, Skillpad has helped customers all over the world with Life Science Industry Knowledge challenges. We are fully dedicated to the idea that Knowledge Consistency is more achievable than ever using the latest technology and advanced knowledge transfer and management tools.

Ireland
USA
Canada
+353-1-687-0400
+1-973-588-4884
+1-514-316-2339

Get In Touch

    Out of Specification and Atypical Results

    An in-depth understanding of Out of Specification (OOS) and Atypical results in pharmaceutical quality control. It examines the definitions, significance, and causes of these results and the regulatory requirements for investigating them. The content outlines the structured investigation process, starting from laboratory assessment to wider, documented procedures, emphasizing the importance of finding an assignable cause, addressing potential laboratory and process errors, and taking corrective actions. Key regulatory standards, such as the FDA’s Barr Decision, are discussed to highlight industry expectations for scientifically defensible investigations and quality assurance.

    Whether for onboarding or annual refresher training, this Module is seamlessly deployable on any LMS and can be tailored to your company’s exact needs.

      Duration: 30 Mins
    Grade: Core Library

    SKU: PGL-1200-SPL04-EN Categories: , Tag:

    Description

    Learning Objectives:

    • Define the terms ‘Out Of Specification’ (OOS) and ‘Atypical Results’
    • Explain why OOS and Atypical Results are important
    • Describe how these results can occur
    • Describe ways in which OOS and Atypical Results can be prevented
    • Describe the sequence of steps taken to investigate OOS and Atypical Results

    Learner Benefits:

    • Clear Understanding of OOS and Atypical Results: Gain a comprehensive understanding of OOS and Atypical results, their definitions, and why addressing these outcomes is crucial in pharmaceutical quality assurance.
    • Knowledge of Regulatory Requirements for Investigations: Learn about regulatory mandates such as the FDA’s Barr Decision, emphasizing the need for thorough documentation and scientifically sound investigations of OOS results.
    • Insight into Investigation Processes and Protocols: Acquire step-by-step knowledge of laboratory and production investigations, including initial assessments, identifying assignable causes, retesting protocols, and conditions for resampling.
    • Skill in Identifying and Mitigating Common Errors: Understand common sources of laboratory errors and process deviations, equipping you with best practices to prevent OOS occurrences, improve testing accuracy, and ensure quality control.

     

    Module Features:

        Animations
       Voice Over
        Knowledge Checks
        Assessments
       SCORM/AICC compatible
        Full Screen

    Keywords

    • Analytical Testing
    • Assignable Cause
    • Atypical Results
    • Barr Decision
    • Investigation Process
    • Laboratory Error
    • Out of Specification (OOS)
    • Process Error
    • Quality Control
    • Regulatory Compliance
    • Standard Operating Procedure (SOP)
    Back To Top
    Your Cart

    Your cart is empty.